Event: 2nd DIA China Annual Meeting
Dates: May 16-19, 2010
Venue: Crowne Plaza Sun Palace Beijing
Contact: Tina Peng
Email: dia@diachina.org
Weblink: http://www.diahome.org/DIAHome/resources/content.aspx?type=eopdf&file=%2fproductfiles%2f22993%2f10975.pdf

China's drug innovation and development are moving ahead rapidly. A local,
as well as global, perspective will help all players involved to exchange critical
information for research and strategic positioning in an increasingly complex
regulatory landscape.

This second DIA China Annual Meeting will serve as an international, neutral
forum for attendees to collectively discuss how China can play a leadership
role in drug development. Speakers from major regulatory agencies, industry,
and academia will present and lead the panels and sessions.

This multidisciplinary meeting will benefi t all professionals from regulatory
agencies and institutions, the biopharmaceutical industry, investigational
sites, contract research organizations, and academia. Together we can better
understand how to reach the next stage for our profession as well as deliver
benefi ts for human health and well-being globally.

KEY SESSIONS AND TOPICS

General Session Topics

- Regulatory Affairs
- Clinical Research
- Pharmacovigilance
- Clinical Data Management and Statistics
- Non-clinical Safety Assessment
- CMC/GMP
- R&D and Biotechnology

WHO SHOULD ATTEND

This program will benefi t individuals involved in:

- Regulatory affairs
- Clinical research
- Drug R&D strategies
-Quality assurance and quality control
- Drug safety and pharmacovigilance
- Strategic sourcing/planning
- Bioinformatics
- Biostatistics

Please click on the following link for event brochure: 2nd DIA China Annual Meeting EN-CN.pdf